Precision Medicine in Gastroenterology: A Paradigm Shift towards
Personalized Therapies

Abhishek      Verma; Ankit      Awasthi
Keywords: Precision medicine, genomic research, gastroenterology, artificial intelligence, patient- centered care, colorectal cancer.
[1]
Seyhan AA, Carini C. Are innovation and new technologies in precision medicine paving a new era in patients centric care? J Transl Med  2019; 17(1): 114.
 [http://dx.doi.org/10.1186/s12967-019-1864-9] [PMID:  30953518]

[2]
Lamb CA, Saifuddin A, Powell N, Rieder F. The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease. Gastroenterology  2022; 162(5): 1525-42.
 [http://dx.doi.org/10.1053/j.gastro.2021.09.077] [PMID:  34995532]

[3]
Kuo CY, Wu JW, Yeh JH, et al. Implementing precision medicine in endoscopy practice. J Gastroenterol Hepatol  2022; 37(8): 1455-68.
 [http://dx.doi.org/10.1111/jgh.15933] [PMID:  35778863]

[4]
Eso Y, Shimizu T, Takeda H, Takai A, Marusawa H. Microsatellite instability and immune checkpoint inhibitors: Toward precision medicine against gastrointestinal and hepatobiliary cancers. J Gastroenterol  2020; 55(1): 15-26.
 [http://dx.doi.org/10.1007/s00535-019-01620-7] [PMID:  31494725]

[5]
Benech N, Sokol H. Fecal microbiota transplantation in gastrointestinal disorders: Time for precision medicine. Genome Med  2020; 12(1): 58.
 [http://dx.doi.org/10.1186/s13073-020-00757-y] [PMID:  32605650]

[6]
Wu Y, Murray GK, Byrne EM, Sidorenko J, Visscher PM, Wray NR. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun  2021; 12(1): 1146.
 [http://dx.doi.org/10.1038/s41467-021-21280-7] [PMID:  33608531]

[7]
Ghaffari P, Shoaie S, Nielsen LK. Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions. J Transl Med  2022; 20(1): 173.
 [http://dx.doi.org/10.1186/s12967-022-03365-z] [PMID:  35410233]

[8]
Behrouzi A, Nafari AH, Siadat SD. The significance of microbiome in personalized medicine. Clin Transl Med  2019; 8(1): e16.
 [http://dx.doi.org/10.1186/s40169-019-0232-y] [PMID:  31081530]

[9]
Muinao T, Boruah DHP, Pal M. Multi-biomarker panel signature as the key to diagnosis of ovarian cancer. Heliyon  2019; 5(12): e02826.
 [http://dx.doi.org/10.1016/j.heliyon.2019.e02826] [PMID:  31867451]

[10]
Marcuello M, Vymetalkova V, Neves RPL, et al. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med  2019; 69: 107-22.
 [http://dx.doi.org/10.1016/j.mam.2019.06.002] [PMID:  31189073]

[11]
Cui M, Zhang DY. Artificial intelligence and computational pathology. Lab Invest  2021; 101(4): 412-22.
 [http://dx.doi.org/10.1038/s41374-020-00514-0] [PMID:  33454724]

[12]
Goodarzian F, Navaei A, Ehsani B, Ghasemi P, Muñuzuri J. Designing an integrated responsive-green-cold vaccine supply chain network using Internet-of-Things: artificial intelligence-based solutions. Ann Oper Res  2022; 328(1): 1-45.
 [PMID:  35540307]

[13]
Heisler C. Patient-centered access to IBD care: A qualitative study. J Crohn’s Colitis  2023; 5(1): otac045.
 [http://dx.doi.org/10.1093/crocol/otac045]

[14]
Strauss AT, Yeh J, Martinez DA, et al. A patient-centered framework for health systems engineering in gastroenterology: Improving inpatient colonoscopy bowel preparation. BMC Gastroenterol  2021; 21(1): 89.
 [http://dx.doi.org/10.1186/s12876-021-01661-4] [PMID:  33639850]

[15]
Chang JW, Dellon ES. Challenges and opportunities in social media research in gastroenterology. Dig Dis Sci  2021; 66(7): 2194-9.
 [http://dx.doi.org/10.1007/s10620-021-07058-3] [PMID:  34052939]

[16]
Noor NM, Sousa P, Paul S, Roblin X. Early diagnosis, early stratification, and early intervention to deliver precision medicine in IBD. Inflamm Bowel Dis  2022; 28(8): 1254-64.
 [http://dx.doi.org/10.1093/ibd/izab228] [PMID:  34480558]

[17]
Mosele F, Remon J, Mateo J, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO precision medicine working group. Ann Oncol  2020; 31(11): 1491-505.
 [http://dx.doi.org/10.1016/j.annonc.2020.07.014] [PMID:  32853681]

[18]
Suri H. Ethical considerations of conducting systematic reviews in educational research.  Systematic Reviews in Educational Research.  Springer 2020; pp. 41-54.
 [http://dx.doi.org/10.1007/978-3-658-27602-7_3]

[19]
Safdar NM, Banja JD, Meltzer CC. Ethical considerations in artificial intelligence. Eur J Radiol  2020; 122: 108768.
 [http://dx.doi.org/10.1016/j.ejrad.2019.108768] [PMID:  31786504]

[20]
Jagirdhar GSK, Perez JA, Perez AB, Surani S. Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease. World J Gastroenterol  2023; 29(36): 5211-25.
 [http://dx.doi.org/10.3748/wjg.v29.i36.5211] [PMID:  37901450]

[21]
Seligson ND, Knepper TC, Ragg S, Walko CM. Developing drugs for tissue‐agnostic indications: A paradigm shift in leveraging cancer biology for precision medicine. Clin Pharmacol Ther  2021; 109(2): 334-42.
 [http://dx.doi.org/10.1002/cpt.1946] [PMID:  32535906]

[22]
Mazloomnejad R, Ahmadi A, Piroozkhah M, et al. Multi-omics data integration in upper gastrointestinal cancers research: A review of concepts, approaches, and application. Research Square 2023.
 [http://dx.doi.org/10.21203/rs.3.rs-2823707/v1]
Cite As
The International Journal of Gastroenterology and Hepatology Diseases

Precision Medicine in Gastroenterology: A Paradigm Shift towards Personalized Therapies
